Enhanced intestinal absorption of vancomycin with Labrasol and D-α-tocopheryl PEG 1000 succinate in rats

International Journal of Pharmaceutics

Volumn 250, Issue 1, 2003, Pages 181-190

  Prasad, Y ^a   Puthli, S P ^a   Eaimtrakarn, Sudarat ^a   Ishida, Makoto ^a   Yoshikawa, Yukako ^a   Shibata, Nobuhito ^a   Takada, Kanji ^a  

^a KYOTO PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Antibiotic; Glycopeptides; Labrasol; Methicillin resistant staphylococci; Vancomycin hydrochloride; Vitamin E TPGS

Indexed keywords

ALPHA TOCOPHEROL; ALPHA TOCOPHERYL POLYETHYLENE GLYCOL SUCCINATE; ALPHA-TOCOPHERYL POLYETHYLENE GLYCOL SUCCINATE; DRUG DERIVATIVE; LABRASOL; MACROGOL DERIVATIVE; ORGANIC COMPOUND; VANCOMYCIN; PENETRATION ENHANCING AGENT; TOCOFERSOLAN;

ANIMAL; AREA UNDER THE CURVE; ARTICLE; EMULSION; INTESTINE ABSORPTION; MALE; RAT; WISTAR RAT; ANIMAL EXPERIMENT; CONTROLLED STUDY; DOSE RESPONSE; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG FORMULATION; HYDROPHILICITY; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; AREA UNDER CURVE; EMULSIONS; INTESTINAL ABSORPTION; MALE; ORGANIC CHEMICALS; POLYETHYLENE GLYCOLS; RATS; RATS, WISTAR; VANCOMYCIN; VITAMIN E;

EID: 0037413364     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5173(02)00544-6     Document Type: Article

References (31)

1. Anderson K.E., Eliot L.A., Stevenson B.R., Rogers J.A. Formulation and evaluation of a folic acid receptor-targeted oral vancomycin liposomal dosage form. Pharm. Res. 18:2001;316-322.
2. Aungst B.J., Saitoh H. Intestinal absorption barriers and transport mechanisms, including secretory transport, for a cyclic peptide, fibrinogen antagonist. Pharm. Res. 13:1996;114-119.
3. Aungst B.J. Intestinal permeation enhancers. J. Pharm. Sci. 89:2000;429-442.
4. Boudreaux J.P., Hayes D.H., Mizrahi S., Maggiore P., Blazek J., Dick D. Use of water-soluble liquid vitamin E to enhance cyclosporine absorption in children after liver transplant. Transplant. Proc. 25:1993;1875.
5. Bryan A.J., Kaur R., Robinson G., Thomas N.W., Wilson C.G. Histological and physiological studies on the intestine of the rat exposed to solutions of Myrj 52 and PEG 2000. Int. J. Pharm. 7:1980;145-156.
6. Chang T., Benet L.Z., Hebert M.F. The effect of water-soluble vitamin E on cyclosporine Pharmacokinetics in healthy volunteers. Clin. Pharmacol. Ther. 59:1996;1-7.
7. Dintaman J.M., Silverman J.A. Inhibition of P-glycoprotein by D-α-tocopheryl polyethylene glycol 1000 succinate (TPGS). Pharm. Res. 16:1999;1550-1556.
8. Eaimtrakarn S., Rama Prasad Y.V., Ohno T., Konishi T., Yoshikawa Y., Shibata N., Takada K. Absorption enhancing effect of Labrasol on the intestinal absorption of insulin. J. Drug Target. 10:2002;255-260.
9. Erickson R. Effect of 16, 16-dimethyl-PGE2 and indomethacin on bile acid-induced intestinal injury and restitution in rats. J. Lab. Clin. Med. 112:1988;735-744.
10. Geary R.S., Schlameus H.W. Vancomycin and insulin used as models for oral delivery of peptides. J. Control. Rel. 23:1993;65-74.
11. Hu Z., Tawa R., Konishi T., Shibata N., Takada K. A novel emulsifier, labrasol, enhances gastrointestinal absorption of gentamicin by inhibiting transporter. Life Sci. 69:2001;2899-2910.
12. Hu Z., Rama Prasad Y.V., Tawa R., Konishi T., Ishida M., Shibata N., Takada K. Diethyl ether fraction of Labrasol having a stronger absorption enhancing effect on gentamicin than Labrasol itself. Int. J. Pharm. 234:2002;223-235.
13. Hunter J., Hirst B.H., Simmons N. Drug absorption limited by P-glycoprotein-mediated secretory drug transport in human intestinal epithelial Caco-2 cell layers. Pharm. Res. 10:1993;743-749.
14. Jackson M.J. Johnson L.R. Physiology of Gastrointestinal Tract. second ed. 1987;1597-1621 Raven Press, New York.
15. Kajita M., Morishita M., Takayama K., Chiba Y., Tokiwa S., Nagai T. Enhanced enteral bioavailability of vancomycin using water-in-oil-in-water multiple emulsion incorporating highly purified unsaturated fatty acid. J. Pharm. Sci. 89:2000;1243-1252.
16. Kim H.J., Yoon K.A., Hahn M., Park E.S., Chi S.C. Preparation and in vitro evaluation of self-microemulsifying drug delivery systems containing idebenone. Drug Dev. Ind. Pharm. 26:2000;523-529.
17. Kommuru T.R., Gurley B., Khan M.A., Reddy I.K. Self-emulsifying drug delivery systems (SEDDS) of coenzyme Q10: formulation development and bioavailability assessment. Int. J. Pharm. 212:2001;233-246.
18. Krasavage W.J., Terhaar C.J. D-α-tocopheryl polyethylene glycol 1000 Succinate. Acute toxicity, subchronic feeding, reproduction and teratologic studies in the rat. Agric. Food Chem. 25:1977;273-278.
19. Kreilgaard M., Pedersen E.J., Jaros Zewski J.W. NMR characterization and transdermal drug delivery potential of microemulsion systems. J. Control. Rel. 69:2000;421-423.
20. Liu D.Z., LeCluyse E.L., Thakker D.R. Dodecylphosphocholine-mediated enhancement of paracellular permeability and cytotoxicity in Caco-2 cell monolayers. J. Pharm. Sci. 88:1999;1161-1168.
21. Lucas R.A., Bowtle W.J., Ryden R. Disposition of vancomycin in healthy volunteers from oral solution and semi-solid matrix capsules. J. Clin. Pharm. Ther. 12:1987;27-31.
22. Madara J.L. Loosening tight junctions. Lessons from the intestine. J. Clin. Invest. 83:1989;1089-1094.
23. Nakanishi K., Masada M., Nadai T. Effect of Pharmaceutical adjuvants on the rectal permeability of drugs. III. Effect of repeated administration and recovery of the permeability. Chem. Pharm. Bull. 31:1983;4161-4166.
24. Rhee Y.S., Choi J.G., Park E.S., Chi S.C. Transdermal delivery of ketoprofen using microemulsions. Int. J. Pharm. 228:2001;161-170.
25. Shibata N., Ohno T., Shimokawa T., Hu Z., Yoshikawa Y., Koga K., Murakami M., Takada K. Application of pressure-controlled colon delivery capsule to oral administration of glycyrrhizin in dogs. J. Pharm. Pharmacol. 53:2001;441-447.
26. Sokol R.J., Johnson K.E., Karrer F.M., Narkewicz M.R., Smith D., Kam I. Improvement of cyclosporin absorption in children after liver transplantation by means of water-soluble vitamin E. Lancet. 338:1991;212-215.
27. Swenson E.S., Curatolo W.J. © Means to enhance penetration (2) Intestinal permeability enhancement for proteins, peptides and other polar drugs: mechanisms and potential toxicity. Adv. Drug Delivery Rev. 8:1992;39-92.
28. Traber M.G., Kayden H.J., Greem J.B., Green M.H. Absorption of water-miscible forms of vitamin E in a patient with choleostasis and in thoracic duct cannulated rats. Am. J. Clin. Nutr. 44:1986;914-923.
29. Tran H.S., Malli D., Chrzanowski F.A., Puc M.M., Matthews M.S., Hewitt C.W. Site-specific immunosuppression using a new formulation of topical cyclosporine A with polyethylene glycol-8 glyceryl caprylate/caprate. J. Surg. Res. 83:1999;136-140.
30. Wu S.H., Hopkins W.K. Characteristics of D-α-tocopheryl PEG 1000 succinate for applications as an absorption enhancer in drug delivery systems. Pharm. Tech. 23:1999;52-60.
31. Yoshikawa Y., Kato K., Sone H., Takada K. Development and evaluation of noncompartmental pharmacokinetic analysis program 'WINHARMONY'using Visual BASIC language having a function of an automatic recognition of terminal elimination phase of plasma drug concentration vs. time profile. Jpn. J. Clin. Pharm. 29:1998;475-487.